×
Entrez Id:
2146
Gene Symbol:
EZH2
EZH2
0.400
AlteredExpression
group
BEFREE
Loss of Skp2 resulted in a striking decrease of Ezh2 levels in Pten/Trp53 double-null MEFs and in prostate tumors of Pten/Trp53 double-null mutant mice.
27869166
2017
×
Entrez Id:
2146
Gene Symbol:
EZH2
EZH2
0.400
AlteredExpression
group
BEFREE
Chromatin regulators ANCCA and EZH2 are overexpressed in prostate cancer and play crucial roles in androgen-stimulated and castration-refractory prostate tumor growth and survival.
23038103
2013
×
Entrez Id:
2146
Gene Symbol:
EZH2
EZH2
0.400
Biomarker
group
BEFREE
UHRF1 expression was negatively correlated with several tumour suppressor genes and positively with the histone methyltransferase (HMT) EZH2 both in prostate tumours and cell lines.
22330138
2012
×
Entrez Id:
2146
Gene Symbol:
EZH2
EZH2
0.400
Biomarker
group
CTD_human
Down-regulation of the histone methyltransferase EZH2 contributes to the epigenetic programming of decidualizing human endometrial stromal cells.
21903722
2011
×
Entrez Id:
2146
Gene Symbol:
EZH2
EZH2
0.400
Biomarker
group
BEFREE
Polycomb Group protein enhancer of zeste 2 (EZH2 ) was found to be overexpressed in metastatic prostate tumors , and is considered an excellent candidate for such a biomarker.
20087897
2010
×
Entrez Id:
2146
Gene Symbol:
EZH2
EZH2
0.400
Biomarker
group
LHGDN
The Polycomb Group protein EZH2 regulates actin polymerization in human prostate cancer cells.
18095286
2008
×
Entrez Id:
2146
Gene Symbol:
EZH2
EZH2
0.400
Biomarker
group
LHGDN
Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features.
17134822
2007
×
Entrez Id:
2146
Gene Symbol:
EZH2
EZH2
0.400
AlteredExpression
group
LHGDN
Identification of enhancer of zeste homolog 2 expression in peripheral circulating tumor cells in metastatic prostate cancer patients: a preliminary study.
18159594
2007
×
Entrez Id:
2146
Gene Symbol:
EZH2
EZH2
0.400
Biomarker
group
LHGDN
The gene encoding the prostatic tumor suppressor PSP94 is a target for repression by the Polycomb group protein EZH2.
17237810
2007
×
Entrez Id:
2146
Gene Symbol:
EZH2
EZH2
0.400
PosttranslationalModification
group
LHGDN
Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer.
18637271
2007
×
Entrez Id:
2146
Gene Symbol:
EZH2
EZH2
0.400
Biomarker
group
CTD_human
Integrative molecular concept modeling of prostate cancer progression.
17173048
2007
×
Entrez Id:
2146
Gene Symbol:
EZH2
EZH2
0.400
Biomarker
group
CTD_human
Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells.
17003774
2007
×
Entrez Id:
2146
Gene Symbol:
EZH2
EZH2
0.400
AlteredExpression
group
LHGDN
The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer.
16575874
2006
×
Entrez Id:
2146
Gene Symbol:
EZH2
EZH2
0.400
Biomarker
group
LHGDN
Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.
16963837
2006
×
Entrez Id:
2146
Gene Symbol:
EZH2
EZH2
0.400
AlteredExpression
group
LHGDN
Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer.
15817459
2005
×
Entrez Id:
2146
Gene Symbol:
EZH2
EZH2
0.400
AlteredExpression
group
LHGDN
The polycomb group protein EZH2 is involved in progression of prostate cancer.
12374981
2002